ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Get Free Report) shares fell 1.7% during trading on Monday . The stock traded as low as $37.91 and last traded at $37.92. 29,943 shares changed hands during trading, an increase of 179% from the average session volume of 10,717 shares. The stock had previously closed at $38.56.
ALPS Medical Breakthroughs ETF Price Performance
The business’s 50-day moving average is $38.62 and its two-hundred day moving average is $36.65.
Hedge Funds Weigh In On ALPS Medical Breakthroughs ETF
Hedge funds have recently modified their holdings of the stock. International Assets Investment Management LLC acquired a new position in ALPS Medical Breakthroughs ETF during the third quarter valued at approximately $61,430,000. Griffin Asset Management Inc. boosted its holdings in shares of ALPS Medical Breakthroughs ETF by 31.2% in the 3rd quarter. Griffin Asset Management Inc. now owns 30,135 shares of the company’s stock valued at $1,125,000 after buying an additional 7,170 shares during the last quarter. Ridgewood Investments LLC bought a new position in shares of ALPS Medical Breakthroughs ETF in the second quarter valued at $675,000. Jane Street Group LLC acquired a new position in ALPS Medical Breakthroughs ETF during the third quarter worth $366,000. Finally, Financial Advocates Investment Management raised its position in ALPS Medical Breakthroughs ETF by 5.3% during the second quarter. Financial Advocates Investment Management now owns 7,670 shares of the company’s stock worth $258,000 after acquiring an additional 385 shares in the last quarter.
ALPS Medical Breakthroughs ETF Company Profile
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.
See Also
- Five stocks we like better than ALPS Medical Breakthroughs ETF
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- How to Master Trading Discipline: Overcome Emotional Challenges
- Health Care Stocks Explained: Why You Might Want to Invest
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.
